Profiles
Bonnie Bereznicki
Bonnie Bereznicki
Senior Lecturer in Pharmacological Sciences
Room Level 2, 243-09 , MS2
+61 3 6226 4624 (phone)
Dr Bonnie Bereznicki is a pharmacist and part-time early-mid career academic. She completed her PhD in 2011, which focused on using a computerised solution to improve the management of asthma and chronic obstructive pulmonary disease. Her research interests have since expanded to improving the quality use of medicines, and she has led several national research projects examining how patients’ knowledge, expectations and perceptions impact their health outcomes. Dr Bereznicki has been a Lecturer in Pharmacological Sciences at the School of Medicine since 2011 and has taught across several pharmacology units in different courses within the School.
Biography
Dr Bereznicki graduated from the Tasmanian School of Pharmacy in 2002. She worked as a community pharmacist in pharmacies throughout Tasmania and Queensland, before returning to the University of Tasmania in 2007 to undertake postgraduate research degrees in pharmacy. She graduated with first class Honours in 2007, and then received an Australian Postgraduate Award to undertake her PhD, which she completed in 2011. Dr Bereznicki’s PhD research focused on using a computerised solution (data mining) within community pharmacies to identity and subsequently educate people with poorly managed asthma and chronic obstructive pulmonary disease. She has since developed a strong record in respiratory and quality use of medicines research and has been a member of the Tasmania Asthma Foundation’s Medical and Scientific Advisory committee since 2009. Dr Bereznicki has attracted more than $2 million in competitive funding and published 28 original and professional peer-reviewed papers during her career. Bonnie is also a Lecturer in Pharmacological Sciences at the School of Medicine and supervises several Honours and PhD students within the school.
Career summary
Qualifications
| Degree | Thesis title | University | Country | Date |
|---|---|---|---|---|
PhD | Improving the management of asthma and chronic obstructive pulmonary disease | University of Tasmania | Australia | 2011 |
BPharm (Hons) (1st Class) | University of Tasmania | Australia | 2007 | |
BPharm | University of Tasmania | Australia | 2002 |
Memberships
Professional practice
- Member of Asthma Foundation of Tasmania's Medical and Scientific Advisory Committee
Administrative expertise
- Managing small and large scale research projects, unit development and coordination.
Teaching
Pharmacology, Pharmacy, Medicine, Paramedicine
Teaching expertise
Dr Bereznicki was employed as a Lecturer in Pharmacological Sciences in 2011, to develop and coordinate a pharmacology unit for the new Bachelor of Paramedic Practice course. Her performance in this role resulted in further curriculum development responsibilities in the Bachelor of Pharmacy course. In 2016 she made a successful transition to take over the pharmacology teaching in the Bachelor of Medicine, Bachelor of Surgery (MBBS) course and is currently designing, coordinating and delivering the pre-clinical MBBS pharmacology curriculum.
Teaching responsibility
- CAM101 Foundations of Medicine 1 (pharmacology lecturer)
- CAM102 Foundations of Medicine 2 (pharmacology lecturer)
- CAM201 Fundamentals of Clinical Science 1 (pharmacology lecturer)
- CAM202 Fundamentals of Clinical Science 2 (pharmacology lecturer)
Research Appointments
- Medical and Scientific Advisory Committee, Tasmanian Asthma Foundation, 2009-present.
- University of Sydney: PhD thesis examiner, 2018.
- University of Sydney: Masters thesis examiner, 2015.
- Health Education Research (Q1, IF 1.67): manuscript referee, 2015.
- Journal of Clinical Pharmacy and Therapeutics (Q2, IF 1.67): manuscript referee, 2015.
- National Expert Panel for Asthma Adherence, Woolcock Institute of Medical Research, 2011.
- National COPD Expert Reference Panel, Australian Primary Care Collaboratives, 2009.
- National Expert Panel for COPD Medication Persistence, Boehringer Ingelheim, 2009.
- Asthma NSW Research Program (Asthma Foundation of NSW): research grant referee, 2010.
Research Invitations
- Australasian Asthma Conference, Adelaide 2017: Understanding patients’ asthma perceptions to improve medication adherence (invited plenary speaker).
- Asthma Australia: Connecting Asthma Care, Hobart 2016: Factors associated with overestimation of asthma control (invited symposium speaker).
View more on Dr Bonnie Bereznicki in WARP
Expertise
- Management of asthma
- Management of chronic obstructive pulmonary disease
- Quality use of medicines
- Medication outcomes and education
- Drug-related problems
- Health knowledge, beliefs and behaviours
- Childhood ailments
Research Themes
Dr Bereznicki’s research aligns with the University’s research theme of Better Health. Her research interests include the management of asthma and chronic obstructive pulmonary disease, as well as other health conditions. She has a particular interest in how patients’ knowledge, expectations and perceptions impact their medication taking behaviour and health outcomes and has led a number of national research projects in this area. Dr Bereznicki’s research has an underlying emphasis on quality use of medicines – improving guideline-recommended management and minimising adverse drug reactions. Her expertise in this area has expanded to a number of other therapeutic areas, such as childhood fever, atrial fibrillation and adverse drug reactions in the elderly.
Collaboration
Dr Bereznicki is currently involved in a $2.2 million project to support the development of a national Pharmacy Asthma Service. This multicentre project is a collaboration between the University of Tasmania, Woolcock Institute, University of Sydney, Curtin University, Pharmaceutical Society of Australia, Pharmacy Guild of Australia, National Asthma Council and the George Institute for Global Health.
Awards
- Australian Postgraduate Award – PhD scholarship recipient, 2008
- Tasmanian Young Achievers Awards – Semi Finalist, science and technology category, 2008
Current projects
Dr Bereznicki is currently involved in several research projects, both as an investigator and supervisory role. Titles of current projects include:
- Getting asthma under control using the skills of the community pharmacist
- Retrospective evaluation of COPD readmission risk factors profile in Tasmania
- Preventing adverse drug reactions in older people following hospital-discharge
- Management of childhood fever – an investigation of health professionals’ knowledge and preferred treatment options
- Inhaled corticosteroids in respiratory disease – an evaluation of how well patients adhere to advice designed to reduce adverse effects
- Prevalence, patterns and predictors of adverse drug reactions that lead to recurrent hospital admissions in Tasmania
Fields of Research
- Clinical pharmacy and pharmacy practice (321403)
- Respiratory diseases (320103)
- Health services and systems (420399)
- Clinical pharmacology and therapeutics (321402)
- Pharmaceutical sciences (321405)
- Health and community services (420305)
- Preventative health care (420605)
- Basic pharmacology (321401)
- Paediatrics (321399)
- Pharmacology and pharmaceutical sciences (321499)
- Medicine, nursing and health curriculum and pedagogy (390110)
- Health promotion (420603)
- Disease surveillance (420202)
- Aged health care (420301)
- Residential client care (420320)
- Health economics (380108)
- Community child health (420601)
- Infant and child health (321302)
- Toxicology (incl. clinical toxicology) (321407)
- Health informatics and information systems (420308)
- Primary health care (420319)
- Health counselling (420307)
Research Objectives
- Clinical health (200199)
- Other health (209999)
- Preventive medicine (200412)
- Neonatal and child health (200506)
- Health related to ageing (200502)
- Treatment of human diseases and conditions (200105)
- Health education and promotion (200203)
- Evaluation of health outcomes (200202)
- Expanding knowledge in the health sciences (280112)
- Allied health therapies (excl. mental health services) (200301)
- Evaluation of health and support services (200299)
- Diagnosis of human diseases and conditions (200101)
- Efficacy of medications (200102)
- Specific population health (excl. Indigenous health) (200599)
- Health policy evaluation (200205)
- Assessment, development and evaluation of curriculum (160301)
- Public health (excl. specific population health) (200499)
- Higher education (160102)
- Behaviour and health (200401)
- Health status (incl. wellbeing) (200407)
Publications
Dr Bereznicki has published 20 peer-reviewed original research papers, including 12 papers in Q1 journals. Her first research paper detailed a pharmacy asthma trial that I conducted and was published in the Medical Journal of Australia, the country’s leading peer-reviewed general medical journal. This paper has been cited 43 times and led to further research focusing on new roles for pharmacists in asthma management. Dr Bereznicki subsequently built collaborations with pharmacy practice researchers around the country, obtaining funds for multicentre pharmacy asthma trials with further peer-reviewed research publications in this area, which have collectively been cited 152 times.
In addition to traditional research publications, Dr Bereznicki has published 8 papers in national pharmacy practice publications. These papers focus on the management of asthma and COPD and the importance of evidence-based practice in pharmacy. These papers have been used by thousands of pharmacists around Australia as a form of continuing professional development.
Total publications
82
Journal Article
(48 outputs)| Year | Citation | Altmetrics |
|---|---|---|
| 2023 | Lartey ST, Lung T, Serhal S, Bereznicki L, Bereznicki B, et al., 'Healthcare expenditure and its socio-demographic and clinical predictors in Australians with poorly controlled asthma', PLoS One, 18, (1) pp. 1-16. ISSN 1932-6203 (2023) [Refereed Article] DOI: 10.1371/journal.pone.0279748 [eCite] [Details] Co-authors: Bereznicki L | |
| 2022 | Chidiamara Noku M, Wimmer BC, Peterson GM, Kinsman Leigh, Bereznicki BJ, 'Hospital readmission due to chronic obstructive pulmonary disease: a longitudinal study', International Journal of Health Policy and Management pp. 1-9. ISSN 2322-5939 (2022) [Refereed Article] DOI: 10.34172/ijhpm.2022.5770 [eCite] [Details] Co-authors: Wimmer BC; Peterson GM | |
| 2022 | Schmid O, Bereznicki B, Peterson GM, Stankovich J, Bereznicki L, 'Persistence of Adverse drug reaction-related hospitalization risk following discharge', International journal of environmental research and public health, 9, (19) Article 5585. ISSN 1660-4601 (2022) [Refereed Article] DOI: 10.3390/ijerph19095585 [eCite] [Details] Co-authors: Schmid O; Peterson GM; Stankovich J; Bereznicki L | |
| 2022 | Serhal S, Armour C, Billot L, Krass I, Emmerton L, et al., 'Integrating pharmacy and registry data strengthens clinical assessments of patient adherence', Frontiers in Pharmacology, 13 Article 869162. ISSN 1663-9812 (2022) [Refereed Article] DOI: 10.3389/fphar.2022.869162 [eCite] [Details] Co-authors: Bereznicki L | |
| 2022 | Serhal S, Krass I, Emmerton L, Bereznicki B, Bereznicki L, et al., 'Patient uptake and outcomes following pharmacist-initiated referrals to general practitioners for asthma review', n p j Primary Care Respiratory Medicine pp. 1-8. ISSN 2055-1010 (2022) [Refereed Article] DOI: 10.1038/s41533-022-00315-6 [eCite] [Details] Co-authors: Bereznicki L | |
| 2022 | Serhal S, Mitchell B, Krass I, Emmerton L, Bereznicki B, et al., 'Rethinking the gold standard - The feasibility of randomized controlled trials within health services effectiveness research', Research in social & administrative pharmacy : RSAP, 18, (9) pp. 3656-3668. ISSN 1551-7411 (2022) [Refereed Article] DOI: 10.1016/j.sapharm.2022.03.017 [eCite] [Details] Co-authors: Bereznicki L | |
| 2022 | Serhal S, Saini B, Bosnic-Anticevich S, Emmerton L, Bereznicki B, et al., 'Pharmacist-delivered asthma management services - what do patients think?', Journal of the American Pharmacists Association, 62, (4) pp. 1260-1269. ISSN 1544-3191 (2022) [Refereed Article] DOI: 10.1016/j.japh.2022.02.009 [eCite] [Details] Co-authors: Bereznicki L; Wilson K | |
| 2022 | Serhal S, Saini B, Bosnic-Anticevich S, Krass I, Emmerton E, et al., 'A novel multi-mode education program to enhance asthma care by pharmacists', American journal of pharmaceutical education, 86, (4) Article 8633. ISSN 0002-9459 (2022) [Refereed Article] DOI: 10.5688/ajpe8633 [eCite] [Details] Citations: Scopus - 1Web of Science - 3 Co-authors: Bereznicki L; Wilson K | |
| 2021 | Bereznicki BJ, Caruso V, Errey JA, Parker L, Sward J, et al., 'Interprofessional education for pre-clinical medicine, paramedicine and pharmacy students', Medical Education pp. 1-2. ISSN 0308-0110 (2021) [Contribution to Refereed Journal] DOI: 10.1111/medu.14511 [eCite] [Details] Citations: Scopus - 2Web of Science - 1 Co-authors: Caruso V; Errey JA; Parker L; Sward J; Williams A-MM | |
| 2021 | Borchers-Arriagada N, Jones P, Palmer AJ, Bereznicki B, Cooling N, et al., 'What are the health and socioeconomic impacts of allergic respiratory disease in Tasmania?', Australian Health Review pp. A-I. ISSN 0156-5788 (2021) [Refereed Article] DOI: 10.1071/AH20200 [eCite] [Details] Co-authors: Borchers-Arriagada N; Jones P; Palmer AJ; Cooling N; Johnston J | |
| 2021 | Cousins J, Parameswaran Nair N, Curtain C, Bereznicki B, Wilson K, et al., 'Preventing adverse drug reactions after hospital discharge (PADR-AD): Protocol for a randomised-controlled trial in older people', Research in Social and Administrative Pharmacy ISSN 1934-8150 (2021) [Refereed Article] DOI: 10.1016/j.sapharm.2021.09.007 [eCite] [Details] Citations: Scopus - 2Web of Science - 1 Co-authors: Cousins J; Parameswaran Nair N; Curtain C; Wilson K; Bereznicki L | |
| 2021 | Gaffney GR, Bereznicki LR, Bereznicki BJ, 'Knowledge, beliefs and management of childhood fever among nurses and other health professionals: a cross-sectional survey', Nurse Education Today, 97 Article 104731. ISSN 0260-6917 (2021) [Refereed Article] DOI: 10.1016/j.nedt.2020.104731 [eCite] [Details] Citations: Scopus - 2Web of Science - 1 Co-authors: Gaffney GR; Bereznicki LR | |
| 2021 | Serhal S, Saini B, Bosnic-Anticevich S, Krass I, Emmerton L, et al., 'A targeted approach to improve asthma control using community pharmacists', Frontiers in Pharmacology, 12 Article 798263. ISSN 1663-9812 (2021) [Refereed Article] DOI: 10.3389/fphar.2021.798263 [eCite] [Details] Citations: Scopus - 7Web of Science - 6 Co-authors: Bereznicki L; Wilson K | |
| 2020 | Alqahtani JS, Njoku CM, Bereznicki B, Wimmer BC, Peterson GM, et al., 'Risk factors for all-cause hospital readmission following exacerbation of COPD: a systematic review and meta-analysis', European Respiratory Review, 29, (156) pp. 1-16. ISSN 0905-9180 (2020) [Refereed Article] DOI: 10.1183/16000617.0166-2019 [eCite] [Details] Citations: Scopus - 47Web of Science - 53 Co-authors: Wimmer BC; Peterson GM; Kinsman L | |
| 2020 | Bertilsson E, Serhal S, Emmerton L, Bosnic-Anticevich S, Krass I, et al., 'Pharmacists experience of and perspectives about recruiting patients into a community pharmacy asthma service trial', Research in Social and Administrative Pharmacy, 17, (3) pp. 595-605. ISSN 1934-8150 (2020) [Refereed Article] DOI: 10.1016/j.sapharm.2020.05.012 [eCite] [Details] Citations: Scopus - 3Web of Science - 4 Co-authors: Bereznicki L | |
| 2020 | Curtain CM, Chang JY, Cousins J, Parameswaran Nair N, Bereznicki B, et al., 'Medication regimen complexity index prediction of adverse drug reaction-related hospital admissions', The Annals of Pharmacotherapy, 54, (10) Article 996-1000. ISSN 1060-0280 (2020) [Refereed Article] DOI: 10.1177/1060028020919188 [eCite] [Details] Citations: Scopus - 4Web of Science - 4 Co-authors: Curtain CM; Cousins J; Parameswaran Nair N; Bereznicki L | |
| 2020 | Johnstone LK, Bereznicki BJ, Jacobson G, Thompson AJ, 'Implementation of mouth rinsing after use of inhaled corticosteroids in Australia', International Journal of Clinical Pharmacy ISSN 2210-7703 (2020) [Refereed Article] DOI: 10.1007/s11096-020-01161-7 [eCite] [Details] Citations: Web of Science - 1 Co-authors: Jacobson G; Thompson AJ | |
| 2020 | Njoku CM, Alqahtani JS, Wimmer BC, Peterson GM, Kinsman L, et al., 'Risk factors and associated outcomes of hospital readmission in COPD: a systematic review', Respiratory Medicine, 173 Article 105988. ISSN 0954-6111 (2020) [Refereed Article] DOI: 10.1016/j.rmed.2020.105988 [eCite] [Details] Citations: Scopus - 21Web of Science - 23 Co-authors: Wimmer BC; Peterson GM | |
| 2019 | Wilson KM, Beggs SA, Zosky GR, Bereznicki LR, Bereznicki BJ, 'Parental knowledge, beliefs and management of childhood fever in Australia: a nationwide survey', Journal of Clinical Pharmacy and Therapeutics, 44, (5) pp. 768-774. ISSN 0269-4727 (2019) [Refereed Article] DOI: 10.1111/jcpt.13000 [eCite] [Details] Citations: Scopus - 6Web of Science - 6 Co-authors: Wilson KM; Zosky GR; Bereznicki LR | |
| 2018 | Bereznicki BJ, Tucker MGA, Beggs SA, Zosky GR, Bereznicki LRE, 'Emergency department presentations of febrile children to an Australian public hospital', Journal of Paediatrics and Child Health, 54, (12) pp. 1308-1313. ISSN 1034-4810 (2018) [Refereed Article] DOI: 10.1111/jpc.14071 [eCite] [Details] Citations: Scopus - 5Web of Science - 6 Co-authors: Zosky GR; Bereznicki LRE | |
| 2018 | Obamiro KO, Chalmers L, Lee K, Bereznicki BJ, Bereznicki LR, 'Adherence to oral anticoagulants in atrial fibrillation: an Australian survey', Journal of Cardiovascular Pharmacology and Therapeutics, 23, (4) pp. 337-343. ISSN 1074-2484 (2018) [Refereed Article] DOI: 10.1177/1074248418770201 [eCite] [Details] Citations: Scopus - 23Web of Science - 20 Co-authors: Obamiro KO; Chalmers L; Lee K; Bereznicki LR | |
| 2018 | Obamiro KO, Chalmers L, Lee K, Bereznicki BJ, Bereznicki LRE, 'Anticoagulation knowledge in patients with atrial fibrillation: an Australian survey', International journal of clinical practice, 72, (3) Article e13072. ISSN 1368-5031 (2018) [Refereed Article] DOI: 10.1111/ijcp.13072 [eCite] [Details] Citations: Scopus - 17Web of Science - 21 Co-authors: Obamiro KO; Chalmers L; Lee K; Bereznicki LRE | |
| 2018 | Parameswaran Nair N, Chalmers L, Peterson GM, Bereznicki BJ, Curtain CM, et al., 'Prospective identification versus administrative coding of adverse drug reaction‐related hospitalizations in the elderly: a comparative analysis', Pharmacoepidemiology and Drug Safety, 27, (11) pp. 1281-1285. ISSN 1053-8569 (2018) [Refereed Article] DOI: 10.1002/pds.4667 [eCite] [Details] Citations: Scopus - 11Web of Science - 10 Co-authors: Parameswaran Nair N; Chalmers L; Peterson GM; Curtain CM; Bereznicki LR | |
| 2017 | Bereznicki B, Walters H, Walters J, Peterson G, Bereznicki L, 'Initial diagnosis and management of chronic obstructive pulmonary disease in Australia: views from the coal face', Internal Medicine Journal, 47, (7) pp. 807-813. ISSN 1444-0903 (2017) [Refereed Article] DOI: 10.1111/imj.13418 [eCite] [Details] Citations: Scopus - 4Web of Science - 4 Co-authors: Walters H; Walters J; Peterson G; Bereznicki L | |
| 2017 | Bereznicki BJ, Chapman MP, Bereznicki LRE, 'Factors associated with overestimation of asthma control: a crosssectional study in Australia', Journal of Asthma, 54, (4) pp. 439-446. ISSN 1532-4303 (2017) [Refereed Article] DOI: 10.1080/02770903.2016.1226899 [eCite] [Details] Citations: Scopus - 5Web of Science - 5 Co-authors: Bereznicki LRE | |
| 2017 | Parameswaran Nair N, Chalmers L, Bereznicki BJ, Curtain C, Peterson GM, et al., 'Adverse drug reaction-related hospitalizations in elderly Australians: A prospective cross-sectional study in two Tasmanian hospitals', Drug Safety, 40, (7) pp. 597-606. ISSN 0114-5916 (2017) [Refereed Article] DOI: 10.1007/s40264-017-0528-z [eCite] [Details] Citations: Scopus - 28Web of Science - 25 Co-authors: Parameswaran Nair N; Chalmers L; Curtain C; Peterson GM; Connolly M; Bereznicki LR | |
| 2017 | Parameswaran Nair N, Chalmers L, Bereznicki BJ, Curtain C, Peterson GM, et al., 'Authors' Reply to Mona Kargar and Colleagues' Comment on 'Adverse Drug Reaction-Related Hospitalizations in Elderly Australians: A Prospective Cross-Sectional Study in Two Tasmanian Hospitals'', Drug Safety pp. 1-2. ISSN 0114-5916 (2017) [Letter or Note in Journal] DOI: 10.1007/s40264-017-0613-3 [eCite] [Details] Citations: Web of Science - 3 Co-authors: Parameswaran Nair N; Chalmers L; Curtain C; Peterson GM; Connolly M; Bereznicki LR | |
| 2017 | Parameswaran Nair N, Chalmers L, Bereznicki BJ, Curtain CM, Bereznicki LR, 'Repeat adverse drug reaction-related hospital admissions in elderly Australians: a retrospective study at the Royal Hobart Hospital', Drugs & Aging, 34, (10) ISSN 1170-229X (2017) [Refereed Article] DOI: 10.1007/s40266-017-0490-6 [eCite] [Details] Citations: Scopus - 15Web of Science - 15 Co-authors: Parameswaran Nair N; Chalmers L; Curtain CM; Bereznicki LR | |
| 2016 | Parameswaran Nair N, Chalmers L, Connolly M, Bereznicki BJ, Peterson GM, et al., 'Prediction of hospitalization due to adverse drug reactions in elderly community-dwelling patients (The PADR-EC Score)', PLoS One, 11, (10) pp. 1-17. ISSN 1932-6203 (2016) [Refereed Article] DOI: 10.1371/journal.pone.0165757 [eCite] [Details] Citations: Scopus - 43Web of Science - 38 Co-authors: Parameswaran Nair N; Chalmers L; Connolly M; Peterson GM; Curtain C; Castelino RL; Bereznicki LRE | |
| 2016 | Parameswaran Nair N, Chalmers L, Peterson GM, Bereznicki BJ, Castelino RL, et al., 'Hospitalization in older patients due to adverse drug reactions - the need for a prediction tool', Clinical Interventions in Aging (Online), 11 pp. 497-505. ISSN 1178-1998 (2016) [Refereed Article] DOI: 10.2147/CIA.S99097 [eCite] [Details] Citations: Scopus - 88Web of Science - 86 Co-authors: Parameswaran Nair N; Chalmers L; Peterson GM; Castelino RL; Bereznicki LRE | |
| 2016 | Woodward SC, Bereznicki BJ, Westbury JL, Bereznicki LRE, 'The effect of knowledge and expectations on adherence to and persistence with antidepressants', Patient Preference and Adherence, 10 pp. 761-768. ISSN 1177-889X (2016) [Refereed Article] DOI: 10.2147/PPA.S99803 [eCite] [Details] Citations: Scopus - 13Web of Science - 12 Co-authors: Woodward SC; Westbury JL; Bereznicki LRE | |
| 2015 | Bereznicki BJ, Beggs S, Duff C, Bereznicki L, 'Adherence to management guidelines for childhood asthma in Australia', Australian Family Physician, 44, (12) pp. 933-938. ISSN 0300-8495 (2015) [Refereed Article] PMID: 27054215 [eCite] [Details] Citations: Scopus - 7Web of Science - 6 Co-authors: Beggs S; Bereznicki L | |
| 2015 | Bereznicki BJ, Peterson GM, Jackson SL, Walters E, Hardley FL, et al., 'Describing drivers of and barriers to persistence with tiotropium in patients with chronic obstructive pulmonary disease: A mixed-methods approach', International Journal of Pharmacy Practice, 32, (2) pp. 154-157. ISSN 0961-7671 (2015) [Refereed Article] DOI: 10.1111/ijpp.12129 [eCite] [Details] Citations: Scopus - 5 Co-authors: Peterson GM; Jackson SL; Walters E | |
| 2014 | Bereznicki LRE, Jackson SL, Kromdijk W, Gee P, Fitzmaurice K, et al., 'Improving the management of warfarin in aged-care facilities utilising innovative technology: a proof-of-concept study', International Journal of Pharmacy Practice, 22, (1) pp. 84-91. ISSN 0961-7671 (2014) [Refereed Article] DOI: 10.1111/ijpp.12035 [eCite] [Details] Citations: Scopus - 5 Co-authors: Bereznicki LRE; Jackson SL; Gee P; Fitzmaurice K; Peterson GM | |
| 2013 | Bereznicki BJ, Norton LC, Beggs SA, Gee P, Bereznicki LRE, 'Review of the management of childhood asthma in Tasmania', Journal of Paediatrics and Child Health, 49, (8) pp. 678-683. ISSN 1034-4810 (2013) [Refereed Article] DOI: 10.1111/jpc.12267 [eCite] [Details] Citations: Scopus - 4Web of Science - 4 Co-authors: Beggs SA; Gee P; Bereznicki LRE | |
| 2013 | Bereznicki BJ, Peterson G, Jackson S, Walters EH, George J, et al., 'Uptake and effectiveness of a community pharmacy intervention programme to improve asthma management', Journal of Clinical Pharmacy and Therapeutics,, 38, (3) pp. 212-218. ISSN 1365-2710 (2013) [Refereed Article] DOI: 10.1111/jcpt.12017 [eCite] [Details] Citations: Scopus - 26Web of Science - 24 Co-authors: Peterson G; Jackson S; Walters EH | |
| 2013 | Bereznicki L, Bereznicki B, 'Beta-blockers in asthma', Australian Pharmacist, 32, (5) pp. 54-57. ISSN 0728-4632 (2013) [Contribution to Refereed Journal] Co-authors: Bereznicki L | |
| 2011 | Bereznicki B, Peterson G, Jackson S, Walters EH, DeBoos I, et al., 'Perceived feasibility of a community pharmacy-based asthma intervention: a qualitative follow-up study', Journal of Clinical Pharmacy and Therapeutics, 36, (3) pp. 348-355. ISSN 0269-4727 (2011) [Refereed Article] DOI: 10.1111/j.1365-2710.2010.01187.x [eCite] [Details] Citations: Scopus - 18Web of Science - 15 Co-authors: Peterson G; Jackson S; Walters EH | |
| 2011 | Bereznicki B, Peterson G, Jackson S, Walters EH, Gee P, 'The sustainability of a community pharmacy intervention to improve the quality use of asthma medication', Journal of Clinical Pharmacy and Therapeutics, 36, (2) pp. 144-151. ISSN 0269-4727 (2011) [Refereed Article] DOI: 10.1111/j.1365-2710.2010.01165.x [eCite] [Details] Citations: Scopus - 14Web of Science - 13 Co-authors: Peterson G; Jackson S; Walters EH; Gee P | |
| 2011 | Peterson GM, Bereznicki BJ, 'COPD: the looming epidemic with ageing', Australian Pharmacist, 30, (9) pp. 737-741. ISSN 0728-4632 (2011) [Professional, Non Refereed Article] Co-authors: Peterson GM | |
| 2010 | Bereznicki L, Bereznicki BJ, 'Inhaled anticholinergic medications: their role in COPD and adverse cardiovascular events', Australian Pharmacist, 29, (8) pp. 690-694. ISSN 0728-4632 (2010) [Professional, Non Refereed Article] Co-authors: Bereznicki L | |
| 2009 | Bereznicki BJ, Bereznicki LRE, 'When asthma and COPD overlap each other', Australian Pharmacist, 28, (9) pp. 782-786. ISSN 0728-4632 (2009) [Professional, Non Refereed Article] Co-authors: Bereznicki LRE | |
| 2009 | Bereznicki BJ, Peterson GM, 'COPD is an important health issue in an ageing population', Australian Pharmacist, 28, (9) pp. 742-746. ISSN 0728-4632 (2009) [Refereed Article] Co-authors: Peterson GM | |
| 2008 | Bereznicki BJ, Bereznicki LRE, Peterson GM, 'Strategies to manage asthma', Australian Pharmacist, 27, (5) pp. 414-418. ISSN 0728-4632 (2008) [Professional, Non Refereed Article] Co-authors: Bereznicki LRE; Peterson GM | |
| 2008 | Bereznicki BJ, Bereznicki LRE, Peterson GM, 'Strategies to manage COPD', Australian Pharmacist, 27, (6) pp. 485-491. ISSN 0728-4632 (2008) [Professional, Non Refereed Article] Co-authors: Bereznicki LRE; Peterson GM | |
| 2008 | Bereznicki BJ, Peterson GM, Jackson SL, Walters EH, Fitzmaurice KD, et al., 'Pharmacist-initiated general practitioner referral of patients with suboptimal asthma management', Pharmacy World and Science, 30, (6) pp. 1-7. ISSN 0928-1231 (2008) [Refereed Article] DOI: 10.1007/s11096-008-9242-3 [eCite] [Details] Citations: Scopus - 30Web of Science - 22 Co-authors: Peterson GM; Jackson SL; Walters EH; Fitzmaurice KD; Gee PR | |
| 2008 | Bereznicki BJ, Peterson GM, Jackson SL, Walters EH, Fitzmaurice KD, et al., 'Data-mining of medication records to improve asthma management', Medical Journal of Australia, 189, (1) pp. 21-25. ISSN 0025-729X (2008) [Refereed Article] DOI: 10.5694/j.1326-5377.2008.tb01889.x [eCite] [Details] Citations: Scopus - 36Web of Science - 27 Co-authors: Peterson GM; Jackson SL; Walters EH; Fitzmaurice KD; Gee PR | |
| 2007 | Bereznicki B, Bereznicki L, Jackson S, Peterson G, 'How can pharmacists improve asthma control in the community?', Australian Pharmacist, 26, (7) pp. 566-567. ISSN 0728-4632 (2007) [Professional, Non Refereed Article] Co-authors: Bereznicki L; Jackson S; Peterson G |
Conference Publication
(33 outputs)| Year | Citation | Altmetrics |
|---|---|---|
| 2021 | Cousins J, Parameswaran Nair N, Curtain CM, Bereznicki BJ, Wilson KM, et al., 'Preventing adverse drug reactions after discharge: protocol for a randomised controlled trial in older people', APSA 2021 Annual Conference Book of Oral Abstracts, 06-08 December, online, pp. 251. (2021) [Conference Extract] Co-authors: Cousins J; Parameswaran Nair N; Curtain CM; Wilson KM; Bereznicki LRE | |
| 2021 | Schmid O, Bereznicki B, Peterson G, Stankovich J, Bereznicki LRE, 'The burden of hospital admissions for adverse drug reactions in Tasmania', NPS MedicineWise, 18 May 2021, Online (2021) [Conference Extract] Co-authors: Schmid O; Peterson G; Stankovich J; Bereznicki LRE | |
| 2019 | Bereznicki BJ, Caruso V, Errey JA, Parker L, Sward J, et al., 'Learning together: The paramedic, pharmacy and medical student experience of interprofessional education', PAIC 2019, 28-30 November 2019, Hobart, Tasmania (2019) [Plenary Presentation] Co-authors: Caruso V; Errey JA; Parker L; Sward J; Williams A-MM | |
| 2019 | Njoku CM, Bereznicki BJ, Wimmer BC, Peterson G, Kinsman L, et al., 'A systematic review on risk factors and associated outcomes of hospital readmission in COPD', APSA Annual Conference, 1-4 December 2019, Melbourne, Australia (2019) [Conference Extract] Co-authors: Wimmer BC; Peterson G; Kinsman L | |
| 2017 | Bereznicki BJ, ''My Ventolin controls my asthma' Understanding patients' asthma perceptions to improve medication adherence', 2017 Australasian Asthma Conference, 16-17 October 2017, Adelaide (2017) [Plenary Presentation] | |
| 2017 | Obamiro KO, Chalmers L, Lee K, Bereznicki BJ, Bereznicki LR, 'Gaps in anticoagulation knowledge in patients with atrial fibrillation', ASCEPT ASM / 2017 Annual Scientific Meeting, 5-8 December 2017, Brisbane, Australia (2017) [Conference Extract] Co-authors: Obamiro KO; Chalmers L; Lee K; Bereznicki LR | |
| 2017 | Parameswaran Nair N, Chalmers L, Bereznicki B, Curtain C, Connolly M, et al., 'Readmissions to hospital due to adverse drug reactions in elderly Australians', ISPOR 22nd Annual International Conference, 20-24 May 2017, Boston (2017) [Conference Extract] Co-authors: Parameswaran Nair N; Chalmers L; Curtain C; Connolly M; Bereznicki L | |
| 2017 | Parameswaran Nair N, Chalmers L, Bereznicki B, Curtain CM, Connolly M, et al., 'Repeat Adverse Drug Reactions-related Hospital Admissions in Elderly Australians', International Society for Pharmacoeconomics and Outcomes Research 22nd Annual International Meeting, 20-24 May 2017, Boston (2017) [Conference Extract] Co-authors: Parameswaran Nair N; Chalmers L; Curtain CM; Bereznicki L | |
| 2016 | Bereznicki BJ, Walters EH, Walters JAE, Peterson GM, Bereznicki LRE, 'Under-utilisation of COPD management guidelines in Australian general practice', Respirology, 2-6 April, 2016, Perth, Australia, pp. 101-185. ISSN 1323-7799 (2016) [Conference Extract] DOI: 10.1111/resp.12755 [eCite] [Details] Co-authors: Walters EH; Walters JAE; Peterson GM; Bereznicki LRE | |
| 2016 | Parameswaran Nair N, Chalmers L, Bereznicki BJ, Curtain CM, Peterson GM, et al., 'Adverse drug reaction-related hospitalisation in older patients - A prospective analysis in two hospitals', APSA Annual Conference 2016, 2-5 December, 2016, Sydney, Australia (2016) [Conference Extract] Co-authors: Parameswaran Nair N; Chalmers L; Curtain CM; Peterson GM; Connolly MJ; Bereznicki LRE | |
| 2015 | Bereznicki BJ, Walters EH, Walters JAE, Peterson GM, Bereznicki LRE, 'Diagnosis and management of early COPD in Australia: views from the coal face', 2015 Joint APSA-ASCEPT Annual Conference, 29 November - 2 December, 2015, Hobart, Tasmania (2015) [Conference Extract] Co-authors: Walters EH; Walters JAE; Peterson GM; Bereznicki LRE | |
| 2015 | Chapman M, Bereznicki BJ, Bereznicki LRE, 'Understanding the discrepancy between perceived and actual asthma control in Australia', 2015 Joint APSA-ASCEPT Annual Conference, 29 November - 2 December, 2015, Hobart, Tasmania (2015) [Conference Extract] Co-authors: Bereznicki LRE | |
| 2015 | Parameswaran Nair N, Chalmers L, Bereznicki BJ, Castelino RL, Peterson GM, et al., 'Development of a Score to Predict Hospitalisation due to Adverse Drug Reactions in Older Patients', 2015 Joint APSA-ASCEPT Annual Conference, 29 November - 2 December, 2015, Hobart, Tasmania (2015) [Conference Extract] Co-authors: Parameswaran Nair N; Chalmers L; Castelino RL; Peterson GM; Curtain CM; Connolly MJ; Bereznicki LRE | |
| 2015 | Parameswaran Nair N, Chalmers L, Bereznicki BJ, Peterson GM, Curtain CM, et al., 'Development of a Score to Predict Hospitalisation due to Adverse Drug Reactions in Older Patients', 2015 Joint APSA-ASCEPT Annual Conference, 29 November - 2 December 2015, Hobart, Tasmania (2015) [Conference Extract] Co-authors: Parameswaran Nair N; Chalmers L; Peterson GM; Curtain CM; Connolly MJ; Bereznicki LRE | |
| 2014 | Woodward SC, Bereznicki BJ, Westbury JL, Bereznicki LRE, 'The effect of knowledge and expectations on adherence to and persistence with antidepressants', APSA 2014 Annual Conference, 5-7 December, 2014, Brisbane, Australia (2014) [Conference Extract] Co-authors: Woodward SC; Westbury JL; Bereznicki LRE | |
| 2011 | Norton L, Bereznicki BJ, Bereznicki LRE, Beggs S, 'A review of the management of childhood asthma in Tasmania', APSA 2011 Annual Conference, 11-14 December, 2011, Adelaide, Australia (2011) [Conference Extract] Co-authors: Bereznicki LRE; Beggs S | |
| 2010 | Bereznicki BJ, Jackson SL, Peterson GM, Walters EH, 'The sustainability of a community pharmacy intervention to improve the quality use of asthma medication', National Medicines Symposium 2010 final program and abstract book, 26-28 May 2010 , Melbourne Convention and Exhibition Centre, pp. 202. (2010) [Conference Extract] Co-authors: Jackson SL; Peterson GM; Walters EH | |
| 2010 | Bereznicki BJ, Jackson SL, Peterson GM, Walters EH, George J, et al., 'A community pharmacy intervention program to improve the quality use of asthma medication: participant satisfaction', National Medicines Symposium 2010. Medicines in people's lives - Final program and abstract book, 26-28 May 2010 , Melbourne Convention and Exhibition Centre, pp. 154. (2010) [Conference Extract] Co-authors: Jackson SL; Peterson GM; Walters EH | |
| 2010 | Bereznicki BJ, Jackson SL, Peterson GM, Walters EH, Hardley F, et al., 'Understanding medication persistence in patients with COPD', National Medicines Symposium 2010 final program and abstract book, 26-28 May 2010 , Melbourne Convention and Exhibition Centre, pp. 76. (2010) [Conference Extract] Co-authors: Jackson SL; Peterson GM; Walters EH | |
| 2010 | Bereznicki BJ, Jackson SL, Peterson GM, Walters H, George J, et al., 'A community pharmacy intervention program to improve the management of asthma: uptake and effectiveness', Pharmacy Practice Research Summit 2010 Program, 2-4 March 2010, Rydges Lakeside Canberra , pp. 19. (2010) [Conference Extract] Co-authors: Jackson SL; Peterson GM | |
| 2010 | Bereznicki BJ, Jackson SL, Peterson GM, Walters H, George J, et al., 'A community pharmacy intervention to improve the management of asthma: participant satisfaction', Pharmacy Practice Research Summit 2010 Program, 2-4 March 2010, Rydges Lakeside Canberra , pp. 19. (2010) [Conference Extract] Co-authors: Jackson SL; Peterson GM | |
| 2010 | Bereznicki BJ, Jackson SL, Walters EH, George J, Stewart K, et al., 'A community pharmacy intervention program to improve the quality use of asthma medication: uptake and effectiveness', National Medicines Symposium 2010. Medicines in people's lives - Final program and abstract book, 26-28 May 2010 , Melbourne Convention and Exhibition Centre, pp. 96. (2010) [Conference Extract] Co-authors: Jackson SL; Walters EH | |
| 2010 | Bereznicki BJ, Peterson GM, Jackson SL, Walters EH, DeBoos I, et al., 'Perceived feasibility of a community pharmacy-based asthma intervention: a qualitative follow-up study', National Medicines Symposium 2010 final program and abstract book, 26-28 May, Melbourne Convention and Exhibition Centre, pp. 172. (2010) [Conference Extract] Co-authors: Peterson GM; Jackson SL; Walters EH | |
| 2009 | Bereznicki BJ, Jackson SL, Peterson GM, Gee PR, Fitzmaurice KD, et al., 'Drivers and barriers of tiotropium persistence in patients with chronic obstructive pulmonary disease', Official Journal of the Asian Pacific Society of Respirology, 3-8 April 2009, Darwin Convention Centre, Darwin, pp. 56. (2009) [Conference Extract] Co-authors: Jackson SL; Peterson GM; Gee PR; Fitzmaurice KD; Walters EH | |
| 2009 | Bereznicki BJ, Peterson GM, Jackson SL, Gee PR, Walters EH, 'The sustainability of a community pharmacy intervention to improve the management of asthma', Out of the Wilderness - 2009 APSA Annual Conference program and abstracts booklet, 9-11 December 2009, Wrest Point Convention Centre, Hobart, Tasmania, pp. 86. ISBN 978-0-646-52257-9 (2009) [Conference Extract] Co-authors: Peterson GM; Jackson SL; Gee PR; Walters EH | |
| 2009 | Bereznicki BJ, Peterson GM, Jackson SL, Walters EH, DeBoos I, et al., 'Perceived feasibility of a community pharmacist-led asthma intervention: a qualitative follow-up study', Out of the Wilderness - 2009 APSA Annual Conference program and abstracts booklet, 9-11 December 2009, Wrest Point Convention Centre, Hobart, Tasmania, pp. 172. ISBN 978-0-646-52257-9 (2009) [Conference Extract] Co-authors: Peterson GM; Jackson SL; Walters EH | |
| 2008 | Bereznicki BJ, 'A community pharmacy-based intervention to improve the quality use of asthma medication', QUM - what does it really mean for you? The science, the policy and the practice. Final Program and Abstract Book., 14-16 May 2008, National Convention Centre, Canberra, Australia, pp. 29. (2008) [Conference Extract] | |
| 2008 | Bereznicki BJ, Jackson SL, Peterson GM, Fitzmaurice KD, Gee PR, et al., 'Understanding medication persistence in patients with COPD', Teams for tomorrow, 6-9 December 2008, Canberra, ACT, pp. 108. (2008) [Conference Extract] Co-authors: Jackson SL; Peterson GM; Fitzmaurice KD; Gee PR; Walters EH | |
| 2008 | Bereznicki BJ, Peterson GM, Jackson SL, Walters EH, Fitzmaurice KD, et al., 'The use of pharmacy medication records to prompt GP referral of patients with suboptimal asthma management', Advancing asthma where?, 20-21 October 2008, Sydney, AUST, pp. 42. (2008) [Conference Extract] Co-authors: Peterson GM; Jackson SL; Walters EH; Fitzmaurice KD; Gee PR | |
| 2008 | Bereznicki BJ, Peterson GM, Jackson SL, Walters EH, Gee PR, et al., 'A community pharmacy-based intervention to improve the quality use of asthma medication', QUM - what does it really mean for you? The science, the policy and the practice. Final Program and Abstract Book., 14-16 May 2008, National Convention Centre, Canberra, Australia, pp. 71. (2008) [Conference Extract] Co-authors: Peterson GM; Jackson SL; Walters EH; Gee PR; Fitzmaurice KD | |
| 2008 | Jackson SL, Bereznicki LRE, Gee PR, Fitzmaurice KD, Kromdijk W, et al., 'Innovative IT solutions to improve the management of warfarin', QUM - what does it really mean for you? The science, the policy and the practice. Final Program and Abstract Book., 14-16 May 2008, National Convention Centre, Canberra, Australia, pp. 60. (2008) [Conference Extract] Co-authors: Jackson SL; Bereznicki LRE; Gee PR; Fitzmaurice KD; Kromdijk W; Marsden KA | |
| 2007 | Bereznicki BJ, Peterson GM, Jackson SL, Walters EH, Fitzmaurice KD, et al., 'Data-mining of pharmacy medication records to improve the management of asthma', Australian Pharmaceutical Science Association, 8-11 December 2007, Manly NSW, pp. 205. ISBN 978-0-646-48458-7 (2007) [Conference Edited] Co-authors: Peterson GM; Jackson SL; Walters EH; Fitzmaurice KD; Gee PR | |
| 2007 | Peterson GM, Jackson SL, Gee PR, Bereznicki LRE, Bereznicki BJ, et al., 'Improving the management of warfarin in aged care facilities utilising an innovative IT solution', Australian Pharmaceutical Science Association, 8-11 December 2007, Manly NSW, pp. 205. ISBN 978-0-646-48458-7 (2007) [Conference Edited] Co-authors: Peterson GM; Jackson SL; Gee PR; Bereznicki LRE; Fitzmaurice KD; Kromdijk W |
Other Public Output
(1 outputs)| Year | Citation | Altmetrics |
|---|---|---|
| 2011 | Bereznicki BJ, 'The role of a community pharmacist in asthma management', The Australian College of Pharmacy eNews, The Australian College of Pharmacy, Canberra, 11, November 2011, pp. 1-5. (2011) [Internal Newsletter] |
Grants & Funding
Dr Bereznicki has obtained $2,462,068 in total research funding over the course of her career. She is currently a chief investigator on a $2.2 million project to support the development of a national Pharmacy Asthma Service. This multicentre project is a collaboration between the University of Tasmania, Woolcock Institute, University of Sydney, Curtin University, Pharmaceutical Society of Australia, Pharmacy Guild of Australia, National Asthma Council and the George Institute for Global Health.
Other competitive grants have been awarded from the Royal Hobart Hospital Research Foundation, Asthma Australia and the Department of Health and Ageing. She has also engaged with the pharmaceutical industry and the Asthma Foundation of Tasmania to obtain $111,380 in contract research funding for the investigation and improvement of medication management issues in patients with asthma and COPD.
Funding Summary
Number of grants
10
Total funding
Projects
- Description
- Dementia is a significant risk factor for serious side effects of medicines or adverse drug reactions (ADRs). This prospective study will investigate and identify the prevalence and risk factors for ADR-related hospital admissions in elderly patients with dementia or cognitive impairment.
- Funding
- Royal Hobart Hospital Research Foundation ($9,985)
- Scheme
- Grant-Incubator
- Administered By
- University of Tasmania
- Research Team
- Parameswaran Nair N; Bereznicki LRE; Adamczewski B; Salahudeen MS; Bereznicki BJ
- Year
- 2020
- Description
- Based on our prospective adverse drug reaction (ADR) registry:1*15% of medical admissions to Tasmanian public hospitals in elderly patients were ADR-related,*89% were preventable,*17% patients had a repeat ADR within 12 months, and*One third of patients with repeat ADRs experienced the same ADR caused by the same medications.From this clinical registry, we developed and validated an ADR risk prediction score (PADR-EC).2We hypothesise that ADR risk stratification during hospitalisation and communication of this risk, together with recommendations that target the specific risk factors identified, to GPs at discharge will reduce the risk of ADR-related hospitalisation.Design: A randomised controlled trial (RCT) at the Royal Hobart Hospital, the major public hospital in Tasmania.Population: Over 12-months, 1000 patients ≥65 years with unplanned admissions to medical wards will be recruited and randomly allocated to intervention or control groups.Intervention: A researcher will perform an ADR risk assessment using the PADR-EC Score,2 which is the sum of points assigned to 5 independent predictors of ADR-related hospitalisation. Based on the PADR-EC Score and the specific risk factors identified, recommendations to reduce the risk of ADRs will be determined.Recommendations will relate to:*post-discharge medication management services, *monitoring of specific parameters/medications, and *de-prescribing strategies.The PADR-EC Score and recommendations will be communicated to the patient and clinical team during hospitalisation, and the patient's GP, alongside the usual information, in the electronic discharge summary. Control: Usual hospital care, with GPs receiving the standard discharge summary.Follow up: All participants will be followed by the research team for 12-months to identify ADRs (including their management and outcome) and health services received.Outcomes: ADR-related hospitalisation (primary); ADRs requiring hospital treatment, change in therapy or specific treatment (secondary). The study will be powered to detect a 5% difference in the primary outcome
- Funding
- HCF Health and Medical Research Foundation ($274,000)
- Scheme
- Grant-Health Services Research Program (HCF)
- Administered By
- University of Tasmania
- Research Team
- Bereznicki LRE; Curtain CM; Bereznicki BJ; Cousins JM; Connolly M; Adamczewski B; McKenzie D; Simpson T; Barratt A; Webber E; Parameswaran Nair N
- Period
- 2019 - 2022
- Description
- This project will provide the first economic assessment of the burden of allergic respiratory disease (allergic rhinitis and allergic asthma) in Tasmania. Together, allergic rhinitis and allergic asthma affect over 20% of the Tasmanian population, yet there has been no rigorousanalysis of the health and economic impacts. This project will cost the direct and indirect costs of these conditions across Tasmania. In doing so, we will provide a rigorous evidence base to build a case for allergic respiratory research, and directly inform government and non-government investment in interventions. Our research will be co-designed with expert input from government and non-government stakeholders (Asthma Australia) to ensure alignment with end-user needs.
- Funding
- University of Tasmania ($10,000)
- Scheme
- Grant-Research Enhancement Program
- Administered By
- University of Tasmania
- Research Team
- Johnston F; Palmer AJ; Jones PJ; Bereznicki BJ; Cooling NB; Zosky GR
- Year
- 2019
- Description
- We will conduct a cluster randomised trial, with asthma control being the main inclusion criterion and clinical outcome measured. The three study arms are: Group A (Pharmacy Asthma Service): eligible patients will receive four private consultations with the pharmacist, at baseline, one month, six months (via telephone) and 12 months. The consultations will focus on addressing three key factors associated with uncontrolled asthma: suboptimal adherence characterised by underuse of preventer medication and/or overuse of reliever medication; suboptimal inhaler technique; and/or uncontrolled allergic rhinitis. At each visit, asthma control and a number of secondary outcomes will be assessed. Group B (Low intervention and referral): Patients identified with uncontrolled asthma by the pharmacist will be referred to their general practitioner. Clinical outcomes will be assessed at one month and 12 months. Group C (Usual Care): The third group will be recruited from a comparable sample of patients with asthma, matched by age, gender and asthma control scores from general practice medical records. Asthma control and secondary outcomes for this group will be assessed by the project group at baseline and 12 months.
- Funding
- Department of Health (Cth) ($2,074,100)
- Scheme
- Pharmacy Trial Program (Tranche 2)
- Administered By
- Woolcock Institute of Medical Research
- Research Team
- Armour C; Krass I; Bosnic-Anticevich S; Saini B; Bereznicki LRE; Bereznicki BJ; Emmerton L
- Period
- 2017 - 2020
- Description
- This project will describe the presentations to the Royal Hobart Hospital emergency department by children with fever, investigate the knowledge, beliefs and perceptions about childhood fever among parents and caregivers in Tasmania, and develop an educational package for parents and caregivers about childhood fever.
- Funding
- Royal Hobart Hospital Research Foundation ($9,599)
- Scheme
- Grant-Starter
- Administered By
- University of Tasmania
- Research Team
- Bereznicki BJ; Beggs S; Bereznicki LRE; Zosky GR
- Year
- 2016
- Funding
- University of Tasmania ($10,848)
- Scheme
- Grant-Research Enhancement (REGS)
- Administered By
- University of Tasmania
- Research Team
- Bereznicki BJ
- Year
- 2015
- Funding
- Asthma Foundation of Tasmania ($5,500)
- Scheme
- Contract Research
- Administered By
- University of Tasmania
- Research Team
- Bereznicki BJ; Bereznicki LRE
- Year
- 2011
- Funding
- Boehringer Ingelheim Pty Ltd ($105,880)
- Scheme
- Consultancy
- Administered By
- University of Tasmania
- Research Team
- Jackson SL; Bereznicki BJ; Gee PR; Fitzmaurice KD; Peterson GM
- Year
- 2008
- Funding
- Department of Health and Aged Care ($192,986)
- Scheme
- Grant-PGA Pharmacy Guild-Investigator Initiated
- Administered By
- University of Tasmania
- Research Team
- Jackson SL; Peterson GM; Bereznicki BJ; Gee PR; Fitzmaurice KD; Walters EH; George J; Stewart K; March G
- Period
- 2008 - 2009
- Funding
- Asthma Foundations of Australia ($52,655)
- Scheme
- Grant-Targeted Intervention Grants
- Administered By
- University of Tasmania
- Research Team
- Peterson GM; Bereznicki BJ; Jackson SL; Walters EH
- Period
- 2008 - 2009
Research Supervision
Dr Bereznicki supervises several Honours and PhD students within the School of Medicine. She has supervised projects focusing on the management of numerous medical conditions including in asthma, chronic obstructive pulmonary disease, depression, atrial fibrillation and childhood fever. These projects have focused mainly on quality use of medicines and barriers to optimal disease management, such as patients’ and prescribers’ knowledge, beliefs and behaviours and practices. She also supervises projects focusing on risk of hospitalisation due to adverse drug reactions. Dr Bereznicki looking for PhD candidates with prior research experience, such as Honours, in an area of health and disease management.
Current
2
Completed
3
Current
| Degree | Title | Commenced |
|---|---|---|
| PhD | Recurrent Adverse Drug Reaction-related Hospital Admissions: Prevalence, patients, predictors and presentations | 2016 |
| PhD | Preventing Adverse Drug Reactions in Older People Following Hospitalisation | 2018 |
Completed
| Degree | Title | Completed |
|---|---|---|
| Masters | Risk Factors for Hospital Readmission in Patients with Chronic Obstructive Pulmonary Disease Candidate: Maria Chidiamara Augustina Njoku | 2021 |
| PhD | Assessment of Anticoagulation Knowledge and Adherence in Patients with Atrial Fibrillation Candidate: Kehinde Olufemi Obamiro | 2018 |
| PhD | Hospitalisation in Older Patients due to Adverse Drug Reactions Candidate: Nibu Parameswaran Nair | 2018 |